natgillin/translations-raw huggingface dataset:
Č eská republika BRISTOL-MYERS SQUIBB SPOL.
173 Česká republika BRISTOL- MYERS SQUIBB SPOL.
This leaflet was last approved in
174 Navodilo je bilo odobreno
167 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
175 NAVODILO ZA UPORABO
169 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
176 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
170 Do not open the blister until ready to administer.
177 Pretisnega omota ne odprite, dokler niste pripravljeni, da zdravilo zaužijete.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
178 Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
What ABILIFY looks like and contents of the pack ABILIFY 30 mg orodispersible tablets are round and pink, marked with "A" over "643" on one side and 30 on the other.
Izgled zdravila ABILIFY in vsebina pakiranja Orodisperzibilne tablete so okrogle oblike in roza barve, označene z "A" nad "643" na eni strani in 30 na drugi.
Č eská republika BRISTOL-MYERS SQUIBB SPOL.
179 Česká republika BRISTOL- MYERS SQUIBB SPOL.
This leaflet was last approved in
180 Navodilo je bilo odobreno
173 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
181 NAVODILO ZA UPORABO
175 Tell your doctor immediately if you suffer from muscle stiffness or inflexibility with high fever, sweating, altered mental status, or very rapid or irregular heart beat.
182 Če se pojavi togost ali neprožnost mišic z zvišano telesno temperaturo, znojenje, sprememba duševnega stanja ali zelo hiter ali nepravilen srčni utrip, o tem nemudoma obvestite svojega zdravnika.
Blood pressure-lowering medicines:
Zdravila za znižanje krvnega tlaka:
ABILIFY may increase the effect of medicines used to lower the blood pressure.
ABILIFY lahko zveča učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
Driving and using machines Do not drive or use any tools or machines until you know how ABILIFY affects you.
Vpliv na sposobnost upravljanja vozil in strojev Ne vozite in ne upravljajte orodij ali strojev, dokler ne veste, kako ABILIFY vpliva na vas.
Important information about some of the ingredients of ABILIFY Each ml of ABILIFY oral solution contains 200 mg of fructose and 400 mg of sucrose.
En mililiter peroralne raztopine ABILIFY vsebuje 200 mg fruktoze in 400 mg saharoze.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Če vam je zdravnik povedal, da ste preobčutljivi za nekatere sladkorje, se z njim posvetujte, preden vzamete to zdravilo.
The usual dose is 15 ml solution (corresponding to 15 mg aripiprazole) once a day.
Običajni odmerek je 15 ml raztopine (kar ustreza 15 mg aripiprazola) enkrat na dan.
However your doctor may prescribe a lower or higher dose to a maximum of 30 mg (i. e.
Toda vaš zdravnik vam lahko predpiše odmerek, ki je manjši ali večji, do največ 30 mg (tj.
176 If you have the impression that the effect of ABILIFY is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila ABILIFY premočan ali prešibak, se posvetujte z zdravnikom ali s farmacevtom.
Try to take the ABILIFY oral solution at the same time each day.
183 Prizadevajte si, da bi peroralno raztopino ABILIFY vzeli vsak dan ob istem času.
If you take more ABILIFY than you should If you realise you have taken more ABILIFY oral solution than your doctor has recommended (or if someone else has taken some of your ABILIFY oral solution), contact your doctor right away.
Če ste vzeli večji odmerek zdravila ABILIFY, kot bi smeli Če ugotovite, da ste vzeli več peroralne raztopine ABILIFY, kot vam je priporočil zdravnik (ali če je vašo peroralno raztopino ABILIFY vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Changes in the levels of some blood cells; unusual heart beat, sudden unexplained death, heart attack; allergic reaction (e. g. swelling in the mouth, tongue, face and throat, itching, rash); high blood sugar, onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, low sodium level in the blood; weight gain, weight loss, anorexia; nervousness, agitation, feeling anxious; thoughts of suicide, suicide attempt and suicide; speech disorder, seizure, combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate; fainting, high blood pressure, blockage of a blood vessel by a blood clot formed elsewhere in the body; spasm of the muscles around the voice box, accidental inhalation of food with risk of pneumonia, difficulty in swallowing; inflammation of the pancreas; inflammation of the liver, yellowing of the skin and white part of eyes, reports of abnormal liver test values, abdominal and stomach discomfort, diarrhoea; skin rash and sensitivity to light, unusual hair loss or thinning, excessive sweating; stiffness or cramps, muscle pain, weakness; involuntary loss of urine, difficulty in passing urine; prolonged and/ or painful erection; difficulty controlling core body temperature or overheating, chest pain, and swelling of hands, ankles or feet.
Drugi redki neželeni učinki Spremembe števila nekaterih krvnih celic; nenavaden srčni utrip, nenadna nepojasnjena smrt, srčni infarct; alergijska reakcija (npr. oteklost ust, jezika, obraza in žrela, srbenje, izpuščaj); visok krvni sladkor, pojav sladkorne bolezni (diabetesa) ali njeno poslabšanje, ketoacidoza (ketoni v krvi in urinu) ali koma, nizka koncentracija natrija v krvi; povečanje telesne mase, hujšanje, neješčnost; živčnost, vznemirjenost, občutek tesnobe; razmišljanje o samomoru; poskus samomora in samomor; motnje govora, epileptični napad, kombinacija zvišane telesne temperature, togosti mišic, hitrega dihanja, znojenja, zmanjšane stopnje zavesti in nenadne spremembe krvnega tlaka ter hitrosti srčnega utripa, omedlevica; visok krvni tlak, zamašitev krvne žile s krvnim strdkom, nastalim drugje v telesu; krči mišic v grlu, naključno vdihanje hrane s tveganjem za pljučnico, težave pri požiranju; vnetje trebušne slinavke; vnetje jeter, porumenelost kože in očesnih beločnic, primeri nenormalnih izvidov laboratorijskih jetrnih preiskav, bolečine v trebuhu in želodcu, driska; osip po koži in občutljivost za svetlobo, neobičajno izpadanje ali razredčenje las oz. dlak, prekomerno potenje; togost ali krči, bolečine v mišicah, šibkost; nehotno uhajanje urina, težave pri odvajanju urina; dolgotrajna in/ ali boleča erekcija; težave z uravnavanjem jedrne telesne temperature ali pregretje, bolečina v prsih in zatekanje rok, gležnjev ali stopal.
177 5.
184 5.
HOW TO STOREABILIFY
SHRANJEVANJE ZDRAVILA ABILIFY
Do not use ABILIFY after the expiry date which is stated on the bottle and on the carton.
Zdravila ABILIFY ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na plastenki in na škatli.
The other ingredients are disodium edetate, fructose, glycerin, lactic acid, methyl parahydroxybenzoate (E218), propylene glycol, propyl parahydroxybenzoate (E216), sodium hydroxide, sucrose, purified water, and natural orange cream with other natural flavours.
Pomožne snovi so dinatrijev edetat, fruktoza, glicerol, mlečna kislina, metilparahidroksibenzoat (E218), propilenglikol, propilparahidroksibenzoat (E216), natrijev hidroksid, saharoza, prečiščena voda in naravna aroma pomaranče.
What ABILIFY looks like and contents of the pack ABILIFY 1 mg/ ml oral solution is a clear, colourless to light yellow liquid supplied in bottles with polypropylene child-resistant closure containing 50 ml, 150 ml or 480 ml per bottle.
Na voljo je v plastenkah, ki imajo za otroke varno zaporko iz polipropilena in vsebujejo 50, 150 ali 480 ml.
For any information about this medicine please contact the local representative of the Marketing Authorisation Holder:
Za vse informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
Č eská republika BRISTOL-MYERS SQUIBB SPOL.
185 Česká republika BRISTOL- MYERS SQUIBB SPOL.
This leaflet was last approved in
186 Navodilo je bilo odobreno
179 Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu /.
INFORMATION FOR THE USER
187 NAVODILO ZA UPORABO
ABILIFY 7.5 mg/ ml Solution for Injection aripiprazole
ABILIFY 7, 5 mg/ ml raztopina za injiciranje aripiprazol
Before you use ABILIFY 3.
Kaj morate vedeti, preden boste uporabili zdravilo ABILIFY 3.
How to use ABILIFY 4.
Kako uporabljati zdravilo ABILIFY 4.
Possible side effects 5.
Možni neželeni učinki 5.
How to store ABILIFY 6.
Shranjevanje zdravila ABILIFY 6.
People with this condition may also feel depressed, guilty, anxious or tense. feeling "high", having excessive amounts of energy, needing much less sleep than usual, talking very quickly with racing ideas and sometimes severe irritability.
Osebe s to boleznijo so lahko tudi depresivne, imajo občutek krivde, tesnobnosti ali napetosti. "privzdignjeno" razpoloženje, pretirana energija, zmanjšana potreba po spanju, hitro govorjenje s prehitevajočimi mislimi in občasno hujša razdražljivost.
ABILIFY solution for injection is given when treatment with oral formulations of ABILIFY is not appropriate.
ABILIFY raztopino za injiciranje uporabljamo, če zdravljenje s peroralnimi farmacevtskimi oblikami zdravila ABILIFY ni primerno.
Your doctor will change your treatment to ABILIFY tablets, ABILIFY orodispersible tablets or ABILIFY oral solution as soon as appropriate.
Zdravnik bo takoj, ko bo to mogoče, zdravljenje spremenil in vam predpisal ABILIFY tablete, ABILIFY orodisperzibilne tablete ali ABILIFY peroralno raztopino.
BEFORE YOU USE ABILIFY
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI ZDRAVILO ABILIFY
Do not use ABILIFY if you are allergic (hypersensitive) to aripiprazole or any of the other ingredients of ABILIFY.
Ne uporabljajte zdravila ABILIFY če ste alergični na (preobčutljivi za) aripiprazol ali katero koli sestavino zdravila ABILIFY.
Take special care with ABILIFY Before treatment with ABILIFY, tell your doctor if you suffer from High blood sugar or family history of diabetes Seizure Involuntary, irregular muscle movements, especially in the face Cardiovascular diseases, family history of cardiovascular disease, stroke or "mini" stroke, abnormal blood pressure
Bodite posebno pozorni pri uporabi zdravila ABILIFY Pred začetkom zdravljenja z zdravilom ABILIFY morate obvestiti svojega zdravnika: če imate visok krvni sladkor ali sladkorno bolezen v družini, če imate napade krčev, če imate nehotne, neredne gibe mišic, zlasti na obrazu, če imate srčnožilne bolezni, srčnožilne bolezni v družini, možgansko kap ali "malo" kap, nenormalen krvni tlak.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/ relative should tell your doctor if you have ever had a stroke or "mini" stroke.
188 Če ste starejša oseba in imate demenco (izguba spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/ sorodnik zdravniku povedati, če ste kdaj doživeli možgansko kap ali "malo" kap.
181 Tell the doctor or nurse if you feel dizzy or faint after the injection.
Če ste po prejemu injekcije omotični ali omedlite, o tem obvestite zdravnika ali medicinsko sestro.
Tell your doctor immediately if you are having any thoughts or feelings about hurting yourself.
Če imate misli ali težnje po samopoškodovanju, o tem nemudoma obvestite svojega zdravnika.
Children and adolescents ABILIFY is not for use in children and adolescents as it has not been studied in patients under 18 years.
Otroci in mladostniki Zdravilo ABILIFY ni namenjeno za uporabo pri otrocih in mladostnikih, saj pri bolnikih, mlajših od 18 let, ni bilo raziskano.
Ask your doctor or pharmacist for advice before taking ABILIFY.
Pred uporabo zdravila ABILIFY se posvetujte z zdravnikom ali s farmacevtom.
ABILIFY may increase the effect of medicines used to lower the blood pressure.
Zdravila za zniževanje krvnega tlaka: zdravilo ABILIFY lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
A combination of ABILIFY solution for injection with medicines taken for anxiety might make you feel drowsy or dizzy.
Uporaba ABILIFY raztopine za injiciranje skupaj z zdravili za zdravljenje anksioznosti (tesnobe) lahko povzroči zaspanost ali omotičnost.
Using ABILIFY with food and drink ABILIFY can be administered regardless of meals.
Uporaba zdravila ABILIFY skupaj s hrano in pijačo Zdravilo ABILIFY se lahko uporablja ne glede na obroke.
Alcohol should be avoided when taking ABILIFY.
Med uporabo zdravila ABILIFY ne smete piti alkoholnih pijač.
Pregnancy and breast-feeding You should not use ABILIFY if you are pregnant unless you have discussed this with your doctor.
Nosečnost in dojenje Med nosečnostjo zdravila ABILIFY ne smete uporabljati, če se o tem niste prej posvetovali s svojim zdravnikom.
Be sure to tell your doctor immediately if you are pregnant, think you may be pregnant, or if you are planning to become pregnant.
Če ste noseči, mislite, da ste noseči, ali nameravate zanositi, morate biti povsem prepričani, da ste o tem nemudoma obvestili svojega zdravnika.
Breast-feeding mothers should not take ABILIFY.
Doječe matere zdravila ABILIFY ne smejo uporabljati.
Be sure to tell your doctor immediately if you are breast-feeding.
Če dojite, morate biti povsem prepričani, da ste o tem nemudoma obvestili svojega zdravnika.
Driving and using machines Do not drive or use any tools or machines if you feel drowsy after receiving ABILIFY solution for injection.
Vpliv na sposobnost upravljanja vozil in strojev Če ste po prejemu ABILIFY raztopine za injiciranje zaspani, ne vozite in ne upravljajte orodij ali strojev.
HOW TO USE ABILIFY
Običajni odmerek pri prvem injiciranju je 9, 75 mg (1, 3 ml).
182 ABILIFY solution for injection is ready to use.
ABILIFY raztopina za injiciranje je že pripravljena za uporabo.
If you are concerned that you are given more ABILIFY solution for injection than you feel necessary, tell your doctor or nurse of your concern.
Če vas skrbi, da ste prejeli večji odmerek ABILIFY raztopine za injiciranje kot bi smeli, o tem obvestite zdravnika ali medicinsko sestro.
Only a few doses of ABILIFY solution for injection may be needed.
Potrebnih bo morda le nekaj odmerkov ABILIFY raztopine za injiciranje.
Your doctor will decide when you need another dose of ABILIFY solution for injection.
O potrebnosti naslednjega odmerka ABILIFY raztopine za injiciranje bo presodil zdravnik.
Like all medicines, ABILIFY can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo ABILIFY neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Common side effects (greater than 1 in 100, less than 1 in 10 patients) of ABILIFY solution for injection include sleepiness, dizziness, headache, restlessness, nausea and vomiting.
Pogosti neželeni učinki (pri več kot 1 od 100, manj kot 1 od 10 bolnikov) ABILIFY raztopine za injiciranje so: zaspanost, omotica, glavobol, nemir, občutek siljenja na bruhanje in bruhanje.
Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may have changes in blood pressure, may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate, dry mouth or fatigue.
Občasni neželeni učinki (pri več kot 1 od 1. 000, manj kot 1 od 100 bolnikov) Nekaterim ljudem se lahko spremeni krvni tlak, lahko so omotični, še posebej, če vstanejo iz ležečega ali sedečega položaja, ali občutijo hitro bitje srca, imajo suha usta ali se počutijo utrujeni.
In addition, the following side effects have been seen in patients treated with oral formulations of ABILIFY:
Pri bolnikih, ki so jemali peroralne farmacevtske oblike zdravila ABILIFY, so bili opaženi tudi naslednji neželeni učinki:
Common side effects (greater than 1 in 100, less than 1 in 10 patients) Uncontrollable twitching or jerking movements, headache, tiredness, nausea, vomiting, an uncomfortable feeling in the stomach, constipation, increased production of saliva, light-headedness, trouble sleeping, restlessness, feeling anxious, sleepiness, shaking and blurred vision.
Pogosti neželeni učinki (pri več kot 1 od 100, manj kot 1 od 10 bolnikov) Neobvladljivo trzanje ali krčeviti gibi, glavobol, nenavadna utrujenost, občutek siljenja na bruhanje, bruhanje, neprijeten občutek v želodcu, zaprtje, močnejše izločanje sline, omotičnost, težave s spanjem, nemir, občutek tesnobe, zaspanost, tresenje in zamegljen vid.
Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate.
Občasni neželeni učinki (pri več kot 1 od 1. 000, manj kot 1 od 100 bolnikov) Nekateri ljudje so lahko omotični, še posebej, če vstanejo iz ležečega ali sedečega položaja, ali občutijo hitro bitje srca.
Some people may feel depressed.
Nekateri posamezniki se lahko počutijo depresivni.
Other infrequently reported side effects:
Drugi redki neželeni učinki:
Changes in the levels of some blood cells; unusual heart beat, sudden unexplained death, heart attack; allergic reaction (e. g. swelling in the mouth, tongue, face and throat, itching, rash); high blood sugar, onset or worsening of diabetes, ketoacidosis (ketones in the blood and urine) or coma, low sodium level in the blood; weight gain, weight loss, anorexia; nervousness, agitation, feeling anxious; thoughts of suicide, suicide attempt and suicide; speech disorder, seizure, combination of fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate; fainting, high blood pressure, blockage of a blood vessel by a blood clot formed elsewhere in the body; spasm of the muscles around the voice box, accidental inhalation of food with risk of pneumonia, difficulty in swallowing; inflammation of the pancreas; inflammation of the liver, yellowing of the skin and white part of eyes, reports of abnormal liver test values, abdominal and stomach discomfort, diarrhoea; skin rash and sensitivity to light, unusual hair loss or thinning, excessive sweating; stiffness or cramps, muscle pain, weakness; involuntary loss of urine, difficulty in passing urine; prolonged and/ or painful erection; difficulty controlling core body temperature or overheating, chest pain, and swelling of hands, ankles or feet.
Spremembe števila nekaterih krvnih celic; nenavaden srčni utrip, nenadna nepojasnjena smrt, srčni infarkt; alergijska reakcija (npr. oteklost ust, jezika, obraza in žrela, srbenje, izpuščaj); visok krvni sladkor, pojav sladkorne bolezni (diabetesa) ali njeno poslabšanje, ketoacidoza (ketoni v krvi in urinu) ali koma, nizka koncentracija natrija v krvi; povečanje telesne mase, hujšanje, neješčnost; živčnost, vznemirjenost, občutek tesnobe; razmišljanje o samomoru, poskus samomora in samomor; motnje govora, epileptični napad, kombinacija zvišane telesne temperature, togosti mišic, hitrega dihanja, znojenja, zmanjšane stopnje zavesti in nenadne spremembe krvnega tlaka ter hitrosti srčnega utripa; omedlevica, visok krvni tlak, zamašitev krvne žile s krvnim strdkom, nastalim drugje v telesu; krči mišic v grlu, naključno vdihanje hrane s tveganjem za pljučnico, težave pri požiranju; vnetje trebušne slinavke; vnetje jeter, porumenelost kože in očesnih beločnic, primeri nenormalnih izvidov laboratorijskih jetrnih preiskav, bolečine v trebuhu in želodcu, driska; osip po koži in občutljivost za svetlobo, neobičajno izpadanje ali razredčenje las oz. dlak, prekomerno potenje; togost ali krči, bolečine v mišicah, šibkost; nehotno uhajanje urina, težave pri odvajanju urina; dolgotrajna in/ ali boleča erekcija; težave z uravnavanjem jedrne telesne temperature ali pregretje, bolečina v prsih in zatekanje rok, gležnjev ali stopal.
In elderly patients with dementia, more fatal cases have been reported while taking aripiprazole.
190 Pri starejših bolnikih z demenco je bilo med jemanjem aripiprazola opisanih več smrtnih primerov.
Do not use ABILIFY after the expiry date which is stated on the carton and on the vial.
Zdravila ABILIFY ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in viali.
Each ml contains 7.5 mg aripiprazole.
En ml vsebuje 7, 5 mg aripiprazola.
A vial contains 9.75 mg (1.3 ml) aripiprazole.
Viala vsebuje 9, 75 mg (1, 3 ml) aripiprazola.
The other ingredients are sulfobutylether β -cyclodextrin (SBECD), tartaric acid, sodium hydroxide, and water for injection.
Pomožne snovi so sulfobutileter betaciklodekstrin (SBECD), vinska kislina, natrijev hidroksid in voda za injekcije.
What ABILIFY looks like and contents of the pack The ABILIFY solution for injection is a clear, colourless, aqueous solution.
Izgled zdravila ABILIFY in vsebina pakiranja ABILIFY raztopina za injiciranje je bistra, brezbarvna, vodna raztopina.
Č eská republika BRISTOL-MYERS SQUIBB SPOL.
191 Česká republika BRISTOL- MYERS SQUIBB SPOL.
This leaflet was last approved in
192 Navodilo je bilo odobreno
185
193
Abraxane is a powder that is made up into a suspension for infusion (drip into a vein).
Zdravilo Abraxane je prašek, ki se uporablja za pripravo suspenzije za infundiranje (dajanje tekočine v veno).
It contains the active substance paclitaxel (5 mg/ ml).
Vsebuje zdravilno učinkovino paklitaksel (5 mg/ ml).
Abraxane is used to treat metastatic breast cancer in patients whose first treatment for their metastatic disease has stopped working and for whom standard treatment including an ‘ anthracycline’ (a type of anticancer medicine) is not suitable. ‘ Metastatic’ means that the cancer has spread to other parts of the body.
„ Metastatski “ pomeni, da se je rak razširil na druge dele telesa.
Abraxane is used on its own.
Zdravilo Abraxane se uporablja samostojno.
Abraxane should only be given under the supervision of a specialist cancer doctor in wards that are specialised in giving ‘ cytotoxic’ (cell-killing) medicines.
Zdravilo Abraxane se sme dajati le pod nadzorom onkologa v enoti, ki je specializirana za uporabo „ citotoksičnih “ zdravil (zdravila, ki ubijajo celice).
The recommended dose is 260 mg per square metre of body surface area (calculated using the patient ’ s height and weight).
Priporočeni odmerek je 260 mg na kvadratni meter telesne površine (izračun z uporabo višine in teže bolnika).
It is given over a period of 30 minutes, every three weeks.
Zdravilo se daje 30 minut vsake tri tedne.
The dose may be reduced or treatment interrupted in patients who have certain side effects affecting the blood or the nerves.
Odmerek se lahko zmanjša oz. zdravljenje prekine, če se pri bolnikih pokažejo nekateri neželeni učinki, ki vplivajo na kri ali živce.
Abraxane should not be used in patients who have severe problems with their liver.
Zdravila Abraxane se prav tako ne sme uporabljati pri bolnikih s hudimi težavami z jetri.
The appropriate doses for patients with mild or moderate liver problems or with kidney problems are not known.
Primerni odmerki za bolnike z blagimi do zmernimi težavami z jetri ali težavami z ledvicami niso znani.
The active substance in Abraxane, paclitaxel, belongs to the group of anticancer medicines known as the ‘ taxanes’.
Zdravilna učinkovina zdravila Abraxane, paklitaksel, spada v skupino zdravil proti raku, ki so znana kot „ taksani “.